Applied Dna Sciences Profit Margin

Applied Dna Sciences (APDN) currently reports a profit margin of -3557.55% as of June 2026. That compares with -1125.25% in the prior-year period — down 216.2% year over year. That is below the Materials sector average of 17.01%. Use the charts on this page to explore Applied Dna Sciences's profit margin history and peer comparisons.

Applied Dna Sciences's profit margin decreased from -1125.25% to -3557.55% — a 216.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Dna Sciences's profit margin of -3557.55% is lower than the Materials sector average of 17.01%. That is roughly 21009.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Applied Dna Sciences's current -3557.55% should be judged against Materials norms (sector average: 17.01%) and against APDN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -3557.55%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 17.01%. From there, open related valuation or income-statement pages for Applied Dna Sciences, and consider following APDN for alerts when major investors trade the stock.